The Future of Kawasaki Disease Diagnosis: Liquid Biopsy May Hold the Key
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158062 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kasturi Markandran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kawasaki disease (KD) is a febrile illness characterised by systemic inflammation of small- and medium-sized blood vessels, which commonly occurs in young children. Although self-limiting, there is a risk of developing coronary artery lesions as the disease progresses, with delay in diagnosis and treatment. Unfortunately, the diagnosis of KD continues to remain a clinical dilemma. Thus, this article not only summarises the key research gaps associated with KD, but also evaluates the possibility of using circulating endothelial injury biomarkers, such as circulating endothelial cells, endothelial microparticles and vascular endothelial cell-free DNA, as diagnostic and prognostic tools for KD: a “liquid biopsy” approach. The challenges of translating liquid biopsies to use in KD and the opportunities for improvement in its diagnosis and management that such translation may provide are discussed. The use of endothelial damage markers, which are easily obtained via blood collection, as diagnostic tools is promising, and we hope this will be translated to clinical applications in the near future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
- School of Medicine, Royal College of Surgeons in Ireland, D02 YN77 Dublin, Ireland.
- Division of Cardiology, Department of Paediatrics, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore 119228, Singapore.
- Lee Kong Chian School of Medicine, Experimental Medicine Building, 59 Nanyang Drive, Nanyang Technological University, Singapore 636921, Singapore.
- Institute of Molecular and Cell Biology, 61 Biopolis Drive, Proteos, Singapore 138673, Singapore.
ORCID-Profile: Kasturi Markandran, Karan Attal, Christine Cheung, Ching Kit Chen
Zitieren
APA
Markandran, K., Clemente, K. N. M., Tan, E., Attal, K., Chee, Q. Z., Cheung, C., & Chen, C. K. (2024). The Future of Kawasaki Disease Diagnosis: Liquid Biopsy May Hold the Key. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158062
Vancouver
Markandran K, Clemente KNM, Tan E, Attal K, Chee QZ, Cheung C, et al. The Future of Kawasaki Disease Diagnosis: Liquid Biopsy May Hold the Key. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158062
BibTeX
@article{Markandran2024,
author = {Markandran, Kasturi and Clemente, Kristine Nicole Mendoza and Tan, Elena and Attal, Karan and Chee, Qiao Zhi and Cheung, Christine and Chen, Ching Kit},
title = {The Future of Kawasaki Disease Diagnosis: Liquid Biopsy May Hold the Key},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158062}
}
EUVIMED